TY  - GEN
AU  - Crump,Michael
AU  - Baetz,Tara
AU  - Couban,Stephen
AU  - Belch,Andrew
AU  - Marcellus,Deborah
AU  - Howson-Jan,Kang
AU  - Imrie,Kevin
AU  - Myers,Robert
AU  - Adams,Grenfell
AU  - Ding,Keyue
AU  - Paul,Nancy
AU  - Shepherd,Lois
AU  - Iglesias,Jose
AU  - Meyer,Ralph
TI  - Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG)
SN  - 0008-543X
PY  - 2004///1102
KW  - Administration, Oral
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Cisplatin
KW  - Deoxycytidine
KW  - analogs & derivatives
KW  - Dexamethasone
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Lymphoma, Non-Hodgkin
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Salvage Therapy
KW  - Stem Cell Transplantation
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/cncr.20587
ER  -